Guillain-Barré Syndrome Induced by Campylobacter jejuni

References (68)

1. 1 The genome sequence of the food-borne pathogen Campylobacter jejuni reveals hypervariable sequences [DOI]
2. 2 Campylobacter jejuni Infections: Update on Emerging Issues and Trends [DOI]
3. 3 Epidemiology of Campylobacter jejuni infections in the United States and other industrialized nations
4. 4 Peripheral neuropathies and anti-glycolipid antibodies [DOI]
5. 5 Acute motor axonal neuropathy: A frequent cause of acute flaccid paralysis in China [DOI]
6. 6 A treatable multifocal motor neuropathy with antibodies to GM1 ganglioside [DOI]
7. 7 Serum IgG antibody to ganglioside GQ1b is a possible marker of Miller Fisher syndrome [DOI]
8. 8 Acute motor axonal neuropathy: An antibody‐mediated attack on axolemma [DOI]
9. 9 Pathogenesis of Guillain–Barré syndrome [DOI]
10. 10 Preceding infections, immune factors, and outcome in Guillain–Barre syndrome [DOI]
11. 11 Infectious origins of, and molecular mimicry in, Guillain-Barré and Fisher syndromes [DOI]
12. 12 Animal model of axonal Guillain-Barré syndrome induced by sensitization with GM1 ganglioside [DOI]
13. 13 Association betweenCampylobacterInfection and Guillain‐Barré Syndrome [DOI]
14. 14 Guillain-Barr?? Syndrome [DOI]
15. 15 Guillain-Barré syndrome: An update [DOI]
16. 16 Role of Campylobacter jejuni Infection in the Pathogenesis of Guillain-Barré Syndrome: An Update [DOI]
17. 17 A novel link between Campylobacter jejuni bacteriophage defence, virulence and Guillain–Barré syndrome [DOI]
18. 18 Characterization of the Specific Interaction between Sialoadhesin and Sialylated Campylobacter jejuni Lipooligosaccharides [DOI]
19. 19 A prospective study of acute idiopathic neuropathy. II. Antecedent events. [DOI]
20. 20 Anti‐ganglioside GM1 antibodies in guillain‐barré syndrome and their relationship to Campylobacter jejuni infection [DOI]
21. 21 Campylobacter jejuni strains from patients with guillain‐barré syndrome belong mostly to penner serogrpup 19 and contain β‐N‐acetylglucosamine residues [DOI]
22. 22 Monoclonal antibodies raised against Guillain-Barré syndrome–associated Campylobacter jejuni lipopolysaccharides react with neuronal gangliosides and paralyze muscle-nerve preparations [DOI]
23. 23 Lipopolysaccharides of Campylobacter jejuni serotype O:19: Structures of core oligosaccharide regions from the serostrain and two bacterial isolates from patients with the Guillain-Barre syndrome [DOI]
24. 24 Cytomegalovirus in autoimmunity: T cell crossreactivity to viral antigen and autoantigen glutamic acid decarboxylase [DOI]
25. 25 Frequent presence of anti‐G Q1b antibody in Fisher's syndrome [DOI]
26. 26 Guillain-Barré syndrome and Campylobacter jejuni: a serological study. [DOI]
27. 27 Serologic Evidence of Previous Campylobacter jejuni Infection in Patients with the Guillain-Barre Syndrome [DOI]
28. 28 Role of Infection Due to Campylobacter jejuni in the Initiation of Guillain-Barre Syndrome [DOI]
29. 29 Guillain-Barre syndrome associated with Campylobacter infection. [DOI]
30. 30 Molecular Mimicry between Gangliosides and Lipopolysaccharides ofCampylobacter jejuniIsolated from Patients with Guillain‐Barré Syndrome and Miller Fisher Syndrome [DOI]
31. 31 GM1b is a new member of antigen for serum antibody in Guillain-Barre syndrome [DOI]
32. 32 Guillain-Barre Syndrome- and Miller Fisher Syndrome-Associated Campylobacter jejuni Lipopolysaccharides Induce Anti-GM 1 and Anti-GQ 1b Antibodies in Rabbits [DOI]
33. 33 Axonal Guillain‐Barré syndrome: carbohydrate mimicry and pathophysiology [DOI]
34. 34 The spectrum of immune responses to Campylobacter jejuni and glycoconjugates in Guillain‐Barré syndrome and in other neuroimmunological disorders [DOI]
35. 35 Serum antibodies to GM1, GD1b, peripheral nerve myelin, and Campylobacter jejuni in patients with Guillain‐Barré syndrome and controls: Correlation and prognosis [DOI]
36. 36 Association of IgG anti‐GD1a antibody with severe Guillain–Barré syndrome [DOI]
37. 37 HUMAN AUTOIMMUNE NEUROPATHIES [DOI]
38. 38 Experimental Campylobacter jejuni infection in the chicken: an animal model of axonal Guillain-Barre syndrome. [DOI]
39. 39 Ganglioside Mimicry as a Cause of Guillain-Barre Syndrome [DOI]
40. 40 Enhanced, Sialoadhesin-Dependent Uptake of Guillain-Barré Syndrome-Associated Campylobacter jejuni Strains by Human Macrophages [DOI]
41. 41 Association between glycoconjugate antibodies and Campylobacter infection in patients with Guillain-Barré syndrome [DOI]
42. 42 Lipopolysaccharides from Campylobacter jejuni O:41 Strains Associated with Guillain-Barre Syndrome Exhibit Mimicry of GM 1 Ganglioside [DOI]
43. 43 Anti-ganglioside antibody and neuropathy: review of our research.
44. 44 Guillain-Barré syndrome associated with Campylobacter infection [DOI]
45. 45 Induction of anti-GM1 ganglioside antibodies by Campylobacter jejuni lipopolysaccharides [DOI]
46. 46 Lymphocyte transformation test detects a response to Campylobacter jejuni antigens in patients with Guillain-Barré syndrome [DOI]
47. 47 γδ T cell non-responsiveness in Campylobacter jejuni –associated Guillain-Barre syndrome patients [DOI]
48. 48 Campylobacter Diarrhea and Guillain-Barre Syndrome [DOI]
49. 49 The Guillain-Barré syndrome following Campylobacter enteritis with recovery after plasmapheresis [DOI]
50. 50 Current cases in which epitope mimicry is considered a component cause of autoimmune disease: Guillain-Barré syndrome [DOI]
51. 51 Guillain-Barré syndrome in northern China Relationship to Campylobacter jejuni infection and anti-glycolipid antibodies [DOI]
52. 52 Campylobacter jejuniInfection and Guillain–Barré Syndrome [DOI]
53. 53 Campylobacter Species and Guillain-Barre Syndrome [DOI]
54. 54 A bacterium lipopolysaccharide that elicits Guillain-Barré syndrome has a GM1 ganglioside-like structure. [DOI]
55. 55 Axonal Guillain-Barr� syndrome: Relation to anti-ganglioside antibodies andCampylobacter jejuni infection in Japan [DOI]
56. 56 Anti-GD1a antibody is associated with axonal but not demyelinating forms of Guillain-Barr� syndrome [DOI]
57. 57 Chagas Disease Etiology: Autoimmunity or Parasite Persistence? [DOI]
58. 58 CampylobacterandArcobacter [DOI]
59. 59 Clinical features and response to treatment in Guillain-Barr� syndrome associated with antibodies to GM1b ganglioside [DOI]
60. 60 The risk of Guillain–Barré syndrome following infection with Campylobacter jejuni [DOI]
61. 61 Glycosaminoglycans in autoimmunity.
62. 62 Campylobacter jejuniIsolates from Japanese Patients with Guillain‐Barré Syndrome [DOI]
63. 63 Gangliosides GM1 and GD1b are antigens for IgM M-protein in a patientwith motor neuron disease [DOI]
64. 64 Serologic Evidence of Campylobacter jejuni/coli Enteritis in Patients with Guillain-Barre Syndrome [DOI]
65. 65 GUILLAIN‐BARRÉ SYNDROME ASSOCIATED WITH CAMPYLOBACTER INFECTION [DOI]
66. 66 Immunopathology and Th1/Th2 immune response of Campylobacter jejuni-induced paralysis resembling Guillain–Barré syndrome in chicken [DOI]
67. 67 Campylobacter jejuni/Campylobacter coli ‐associated Guillain‐Barré syndrome [DOI]
68. 68 Isolation and characterisation of T lymphocytes from sural nerve biopsies in patients with Guillain-Barre syndrome and chronic inflammatory demyelinating polyneuropathy. [DOI]

Cited by 0

No indexed citations yet.

Related research

• Association of Multiple Sclerosis with Epstein-Barr virus Infection — shares topic coverage
• Celiac and Non-Celiac Forms of Gluten Sensitivity: Shifting Paradigms of an Old Disease — shares topic coverage
• Reactivity against the Flavine Adenosine Nucleotide (FAD) Cofactor of Bacterial Enzymes May Explain Positive Flavoprotein Antibody Tests in Patients without Ophthalamopathy — shares topic coverage
• Conventional and Nano-Based Therapy against Chronic Inflammatory Autoimmune Diseases — shares topic coverage
• Regulation of TSH Receptor Autoantibodies by a long Non-Coding RNA (Heg) and Cdk1- A Review — shares topic coverage